IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i14p8605-d863079.html
   My bibliography  Save this article

Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals

Author

Listed:
  • Michael Ceulemans

    (Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
    Teratology Information Service, Netherlands Pharmacovigilance Centre Lareb, 5237 MH Hertogenbosch, The Netherlands
    L-C&Y, Child and Youth Institute, KU Leuven, 3000 Leuven, Belgium)

  • Kristel Van Calsteren

    (Department of Obstetrics & Gynecology, University Hospitals Leuven Gasthuisberg, 3000 Leuven, Belgium
    Woman and Child, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium)

  • Karel Allegaert

    (Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
    L-C&Y, Child and Youth Institute, KU Leuven, 3000 Leuven, Belgium
    Woman and Child, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium
    Department of Clinical Pharmacy, Erasmus MC, 3000 CA Rotterdam, The Netherlands)

  • Veerle Foulon

    (Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium)

Abstract

A Teratology Information Service (TIS) does not exist in Belgium yet but will hopefully be established soon. To prepare for this, we aimed to provide insight into the information needs and counseling preferences of the Belgian public and healthcare professionals (HCPs) regarding medication use in pregnancy and breastfeeding. A cross-sectional study using two anonymous, online surveys disseminated via social media, websites, and newsletters addressing Dutch and French-speaking individuals (≥18 years) and licensed HCPs was performed between June and September 2020. Ethics approval and informed consent were obtained. In total, 1508 public survey respondents (98% women) and 702 HCPs participated. Information needs on perinatal medication use were ubiquitous among both groups, and for which they often relied on patient information leaflets or the product information and online fora. Conflicting information on this topic regularly occurs and complicates HCPs’ duties. Women and HCPs assigned an important role to a TIS, both in terms of providing evidence-based information (via a website or app) and being accessible to be contacted in case of questions (by phone or via e-mail or chat). In conclusion, a TIS would be warmly welcomed by women and HCPs in Belgium and should ideally be established soon to address current information needs regarding perinatal medication use and to contribute to research in this field.

Suggested Citation

  • Michael Ceulemans & Kristel Van Calsteren & Karel Allegaert & Veerle Foulon, 2022. "Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals," IJERPH, MDPI, vol. 19(14), pages 1-14, July.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:14:p:8605-:d:863079
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/14/8605/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/14/8605/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Laure Sillis & Veerle Foulon & Jan Y. Verbakel & Michael Ceulemans, 2022. "Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative Analysis," IJERPH, MDPI, vol. 19(7), pages 1-13, April.
    2. Saskia Vorstenbosch & Bernke Winkel & Marleen M. H. J Gelder & Agnes Kant & Nel Roeleveld & Eugène Puijenbroek, 2019. "Aim and Design of pREGnant, the Dutch Pregnancy Drug Register," Drug Safety, Springer, vol. 42(1), pages 1-12, January.
    3. Eva Gerbier & Guillaume Favre & Fatima Tauqeer & Ursula Winterfeld & Milos Stojanov & Alison Oliver & Anneke Passier & Hedvig Nordeng & Léo Pomar & David Baud & Alice Panchaud & Carla Meyer-Massetti &, 2022. "Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study," IJERPH, MDPI, vol. 19(9), pages 1-16, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Karel Allegaert, 2022. "Pharmacotherapy during Pregnancy, Childbirth, and Lactation," IJERPH, MDPI, vol. 19(18), pages 1-5, September.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Karel Allegaert, 2022. "Pharmacotherapy during Pregnancy, Childbirth, and Lactation," IJERPH, MDPI, vol. 19(18), pages 1-5, September.
    2. Mary Ndu & Gail Teachman & Janet Martin & Elysee Nouvet, 2024. "“We Live Our Life Normal”: A Qualitative Analysis of Nigerian Women’s Health-Seeking Behavior during the COVID-19 Pandemic," IJERPH, MDPI, vol. 21(3), pages 1-25, February.
    3. Jonathan L. Richardson & Alan Moore & Rebecca L. Bromley & Michael Stellfeld & Yvonne Geissbühler & Matthew Bluett-Duncan & Ursula Winterfeld & Guillaume Favre & Amalia Alexe & Alison M. Oliver & Yrea, 2023. "Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project," Drug Safety, Springer, vol. 46(5), pages 479-491, May.
    4. Annerose E. van der Mijle & Petra J. Woestenberg & Leanne J. Kosse & Eugène P. van Puijenbroek, 2023. "The Dutch Pregnancy Drug Register: Suitable to Study Paternal Drug Exposures?," IJERPH, MDPI, vol. 20(23), pages 1-9, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:14:p:8605-:d:863079. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.